(Q84801790)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865087%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Acute inflammatory arthritis: interleukin-1 blockade: a magic wand for gout? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865087%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865087%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

1 November 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865087%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Rheumatology

11 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865087%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865087%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865087%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

594-596

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19865087%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrrheum.2009.213

11 February 2020

exact match

0 references

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.213

Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.213

EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.213

British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Gout

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.213

Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.213

Gout-associated uric acid crystals activate the NALP3 inflammasome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.213

A pilot study of IL-1 inhibition by anakinra in acute gout

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.213

The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.213

Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.213

Use of canakinumab in the cryopyrin-associated periodic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.213